Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Minimal Change Disease

Total 22 results

Beom Jin Lim, MD, PhD
Seen in:
- Seoul, Severance Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Dong Ki Kim, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Eunjeong Kang, MD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Eunyoung Kim, BN
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Hajeong Lee, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Hee Gyung Kang, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Jeong Hwan Park, MD
Seen in:
- Seoul, SMG-SNU Boramae Medical Center
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Jeonghwan Lee, MD, PhD
Seen in:
- Seoul, SMG-SNU Boramae Medical Center
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Ji In Park, MD
Seen in:
- Chuncheon, Kangwon National University Hospital
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Jin Ho Hwang, MD, PhD
Seen in:
- Seoul, Chung-Ang University Hosptial
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Jung Nam An, MD, PhD
Seen in:
- Seoul, SMG-SNU Boramae Medical Center
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Jung Pyo Lee, MD, PhD
Seen in:
- Seoul, SMG-SNU Boramae Medical Center
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Jung Tak Park, MD, PhD
Seen in:
- Seoul, Severance Hospital
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Kwon Wook Joo, MD, PhD
Seen in:
- Incheon, Sejoong Kim
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
- NCT01103167 (Sub-Investigator)
Conditions:
Kyung Chul Moon, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Nan Kyung Lee, MS
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Seung Hee Yang, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Seung Seok Han, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Seungyeup Han, MD, PhD
Seen in:
- Daegu, Keimyung University Dongsan Medical Center
Trials:
- NCT03929887 (Principal Investigator)
Conditions:
Sunhwa Lee, MD
Seen in:
- Chuncheon, Kangwon National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Yaerim Kim, MD, PhD
Seen in:
- Daegu, Keimyung University Dongsan Medical Center
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:
Yon Su Kim, MD, PhD
Seen in:
- Seoul, Seoul National University Hospital
Trials:
- NCT03929887 (Sub-Investigator)
Conditions:

Clinical Trials on Minimal Change Disease

Assistance Publique - Hôpitaux de Paris

Recruiting

RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome (RIFIREINS)

Minimal Change Nephrotic Syndrome (MCNS)

France
Astellas Pharma Korea, Inc.

Completed

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome (T-OPTIMUM)

Minimal Change Nephrotic Syndrome (MCNS) | MCNS

Korea, Republic of
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Enrolling by invitation

NEPTUNE Match Study (NEPTUNE Match)

Focal Segmental Glomerulosclerosis | Minimal Change Disease | Membranous Nephropathy | Nephrotic Syndrome in Children | FSGS | MCD | Minimal Change Nephrotic Syndrome | MCD - Minimal Change Disease

United States
University of Aarhus

Active, not recruiting

Active Vitamin D And Reduced Dose Prednisolone for Treatment in Minimal Change Nephropathy (ADAPTinMCN)

Nephrotic Syndrome | Minimal Change Disease

Denmark
Imperial College Healthcare NHS Trust

Completed

Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease (MinTAC)

Minimal Change Disease

United Kingdom
University of Michigan
Northwestern University; Food and Drug Administration (FDA)

Recruiting

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. (Prepare-NS)

Edema | Fluid Overload | Glomerulosclerosis, Focal Segmental | Nephrotic Syndrome | Glomerular Disease | Minimal Change Disease | Membranous Nephropathy | Nephrotic Syndrome in Children | Nephrotic Syndrome, Minimal Change | FSGS | Minimal Change Nephrotic Syndrome | IgM Nephropathy | Nephrotic Syndrome With Edema...

United States
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The...

Recruiting

Nephrotic Syndrome Study Network (NEPTUNE)

Glomerulosclerosis, Focal Segmental | Membranous Nephropathy | Minimal Change Disease (MCD)

United States, Canada
Seoul National University Hospital

Completed

Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome (MCNS)

Minimal Change Disease

Korea, Republic of
Istanbul University

Completed

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Focal Segmental Glomerulosclerosis | Minimal Change Disease

Turkey
Rabin Medical Center

Unknown

Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome (AJSNS)

Nephrotic Syndrome, Minimal Change

Israel

Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Minimal Change Disease

Clinical Trials on Minimal Change Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations